Lung Tumor Market Size, Trend, Growth, Industry Analysis Report 2034
Lung Tumor Market By Product (Targeted Therapies, Chemotherapy Drugs, Imaging Systems, Surgical Instruments, Biopsy Needles & Devices, Radiation Therapy Equipment, and Others), By Application (Treatment, Early Detection, Diagnosis, and Prognosis), By End-User Vertical (Imaging Centers, Cancer Centers, Hospitals & Clinics, and Research Institutions), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034
Category: Healthcare Report Format : PDF
Pages: 227 Report Code: ZMR-10604
Published Date: May-2026 Status : Published
| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 5.82 Billion | USD 10.51 Billion | 6.67% | 2024 |
Table Of Content
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global Lung Tumor Market, (2025 - 2034) (USD Billion)
- 2.2 Global Lung Tumor Market : snapshot
- Chapter 3. Global Lung Tumor Market - Industry Analysis
- 3.1 Lung Tumor Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Advancements toward early diagnosis to promote market growth in the coming years
- 3.3 Market Restraints
- 3.3.1. Limit the expansion of the lung tumor market during the forecast period
- 3.4 Market Opportunities
- 3.4.1. Shifting toward personalized medical care creates expansion possibilities for the market players
- 3.5 Market Challenges
- 3.5.1. The complex biology of lung tumor to challenge market expansion in the coming years
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Product
- 3.7.2 Market attractiveness analysis By Application
- 3.7.3 Market attractiveness analysis By End-User Vertical
- Chapter 4. Global Lung Tumor Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Lung Tumor Market: company market share, 2024
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Lung Tumor Market - Product Analysis
- 5.1 Global Lung Tumor Market overview: By Product
- 5.1.1 Global Lung Tumor Market share, By Product, 2024 and 2034
- 5.2 Targeted Therapies
- 5.2.1 Global Lung Tumor Market by Targeted Therapies, 2025 - 2034 (USD Billion)
- 5.3 Chemotherapy Drugs
- 5.3.1 Global Lung Tumor Market by Chemotherapy Drugs, 2025 - 2034 (USD Billion)
- 5.4 Imaging Systems
- 5.4.1 Global Lung Tumor Market by Imaging Systems, 2025 - 2034 (USD Billion)
- 5.5 Surgical Instruments
- 5.5.1 Global Lung Tumor Market by Surgical Instruments, 2025 - 2034 (USD Billion)
- 5.6 Biopsy Needles & Devices
- 5.6.1 Global Lung Tumor Market by Biopsy Needles & Devices, 2025 - 2034 (USD Billion)
- 5.7 Radiation Therapy Equipment
- 5.7.1 Global Lung Tumor Market by Radiation Therapy Equipment, 2025 - 2034 (USD Billion)
- 5.8 Others
- 5.8.1 Global Lung Tumor Market by Others, 2025 - 2034 (USD Billion)
- 5.1 Global Lung Tumor Market overview: By Product
- Chapter 6. Global Lung Tumor Market - Application Analysis
- 6.1 Global Lung Tumor Market overview: By Application
- 6.1.1 Global Lung Tumor Market share, By Application, 2024 and 2034
- 6.2 Treatment
- 6.2.1 Global Lung Tumor Market by Treatment, 2025 - 2034 (USD Billion)
- 6.3 Early Detection
- 6.3.1 Global Lung Tumor Market by Early Detection, 2025 - 2034 (USD Billion)
- 6.4 Diagnosis
- 6.4.1 Global Lung Tumor Market by Diagnosis, 2025 - 2034 (USD Billion)
- 6.5 Prognosis
- 6.5.1 Global Lung Tumor Market by Prognosis, 2025 - 2034 (USD Billion)
- 6.1 Global Lung Tumor Market overview: By Application
- Chapter 7. Global Lung Tumor Market - End-User Vertical Analysis
- 7.1 Global Lung Tumor Market overview: By End-User Vertical
- 7.1.1 Global Lung Tumor Market share, By End-User Vertical, 2024 and 2034
- 7.2 Imaging Centers
- 7.2.1 Global Lung Tumor Market by Imaging Centers, 2025 - 2034 (USD Billion)
- 7.3 Cancer Centers
- 7.3.1 Global Lung Tumor Market by Cancer Centers, 2025 - 2034 (USD Billion)
- 7.4 Hospitals & Clinics
- 7.4.1 Global Lung Tumor Market by Hospitals & Clinics, 2025 - 2034 (USD Billion)
- 7.5 Research Institutions
- 7.5.1 Global Lung Tumor Market by Research Institutions, 2025 - 2034 (USD Billion)
- 7.1 Global Lung Tumor Market overview: By End-User Vertical
- Chapter 8. Lung Tumor Market - Regional Analysis
- 8.1 Global Lung Tumor Market Regional Overview
- 8.2 Global Lung Tumor Market Share, by Region, 2024 & 2034 (USD Billion)
- 8.3. North America
- 8.3.1 North America Lung Tumor Market, 2025 - 2034 (USD Billion)
- 8.3.1.1 North America Lung Tumor Market, by Country, 2025 - 2034 (USD Billion)
- 8.3.1 North America Lung Tumor Market, 2025 - 2034 (USD Billion)
- 8.4 North America Lung Tumor Market, by Product, 2025 - 2034
- 8.4.1 North America Lung Tumor Market, by Product, 2025 - 2034 (USD Billion)
- 8.5 North America Lung Tumor Market, by Application, 2025 - 2034
- 8.5.1 North America Lung Tumor Market, by Application, 2025 - 2034 (USD Billion)
- 8.6 North America Lung Tumor Market, by End-User Vertical, 2025 - 2034
- 8.6.1 North America Lung Tumor Market, by End-User Vertical, 2025 - 2034 (USD Billion)
- 8.4. Europe
- 8.4.2 Europe Lung Tumor Market, 2025 - 2034 (USD Billion)
- 8.4.2.1 Europe Lung Tumor Market, by Country, 2025 - 2034 (USD Billion)
- 8.4.2 Europe Lung Tumor Market, 2025 - 2034 (USD Billion)
- 8.4 Europe Lung Tumor Market, by Product, 2025 - 2034
- 8.4.1 Europe Lung Tumor Market, by Product, 2025 - 2034 (USD Billion)
- 8.5 Europe Lung Tumor Market, by Application, 2025 - 2034
- 8.5.1 Europe Lung Tumor Market, by Application, 2025 - 2034 (USD Billion)
- 8.6 Europe Lung Tumor Market, by End-User Vertical, 2025 - 2034
- 8.6.1 Europe Lung Tumor Market, by End-User Vertical, 2025 - 2034 (USD Billion)
- 8.5. Asia Pacific
- 8.5.3 Asia Pacific Lung Tumor Market, 2025 - 2034 (USD Billion)
- 8.5.3.1 Asia Pacific Lung Tumor Market, by Country, 2025 - 2034 (USD Billion)
- 8.5.3 Asia Pacific Lung Tumor Market, 2025 - 2034 (USD Billion)
- 8.4 Asia Pacific Lung Tumor Market, by Product, 2025 - 2034
- 8.4.1 Asia Pacific Lung Tumor Market, by Product, 2025 - 2034 (USD Billion)
- 8.5 Asia Pacific Lung Tumor Market, by Application, 2025 - 2034
- 8.5.1 Asia Pacific Lung Tumor Market, by Application, 2025 - 2034 (USD Billion)
- 8.6 Asia Pacific Lung Tumor Market, by End-User Vertical, 2025 - 2034
- 8.6.1 Asia Pacific Lung Tumor Market, by End-User Vertical, 2025 - 2034 (USD Billion)
- 8.6. Latin America
- 8.6.4 Latin America Lung Tumor Market, 2025 - 2034 (USD Billion)
- 8.6.4.1 Latin America Lung Tumor Market, by Country, 2025 - 2034 (USD Billion)
- 8.6.4 Latin America Lung Tumor Market, 2025 - 2034 (USD Billion)
- 8.4 Latin America Lung Tumor Market, by Product, 2025 - 2034
- 8.4.1 Latin America Lung Tumor Market, by Product, 2025 - 2034 (USD Billion)
- 8.5 Latin America Lung Tumor Market, by Application, 2025 - 2034
- 8.5.1 Latin America Lung Tumor Market, by Application, 2025 - 2034 (USD Billion)
- 8.6 Latin America Lung Tumor Market, by End-User Vertical, 2025 - 2034
- 8.6.1 Latin America Lung Tumor Market, by End-User Vertical, 2025 - 2034 (USD Billion)
- 8.7. The Middle-East and Africa
- 8.7.5 The Middle-East and Africa Lung Tumor Market, 2025 - 2034 (USD Billion)
- 8.7.5.1 The Middle-East and Africa Lung Tumor Market, by Country, 2025 - 2034 (USD Billion)
- 8.7.5 The Middle-East and Africa Lung Tumor Market, 2025 - 2034 (USD Billion)
- 8.4 The Middle-East and Africa Lung Tumor Market, by Product, 2025 - 2034
- 8.4.1 The Middle-East and Africa Lung Tumor Market, by Product, 2025 - 2034 (USD Billion)
- 8.5 The Middle-East and Africa Lung Tumor Market, by Application, 2025 - 2034
- 8.5.1 The Middle-East and Africa Lung Tumor Market, by Application, 2025 - 2034 (USD Billion)
- 8.6 The Middle-East and Africa Lung Tumor Market, by End-User Vertical, 2025 - 2034
- 8.6.1 The Middle-East and Africa Lung Tumor Market, by End-User Vertical, 2025 - 2034 (USD Billion)
- Chapter 9. Company Profiles
- 9.1 Exact Sciences Corporation
- 9.1.1 Overview
- 9.1.2 Financials
- 9.1.3 Product Portfolio
- 9.1.4 Business Strategy
- 9.1.5 Recent Developments
- 9.2 F. Hoffmann-La Roche Ltd
- 9.2.1 Overview
- 9.2.2 Financials
- 9.2.3 Product Portfolio
- 9.2.4 Business Strategy
- 9.2.5 Recent Developments
- 9.3 QIAGEN N.V.
- 9.3.1 Overview
- 9.3.2 Financials
- 9.3.3 Product Portfolio
- 9.3.4 Business Strategy
- 9.3.5 Recent Developments
- 9.4 Abbott Laboratories
- 9.4.1 Overview
- 9.4.2 Financials
- 9.4.3 Product Portfolio
- 9.4.4 Business Strategy
- 9.4.5 Recent Developments
- 9.5 Siemens Healthineers AG
- 9.5.1 Overview
- 9.5.2 Financials
- 9.5.3 Product Portfolio
- 9.5.4 Business Strategy
- 9.5.5 Recent Developments
- 9.6 Koninklijke Philips N.V.
- 9.6.1 Overview
- 9.6.2 Financials
- 9.6.3 Product Portfolio
- 9.6.4 Business Strategy
- 9.6.5 Recent Developments
- 9.7 Danaher Corporation
- 9.7.1 Overview
- 9.7.2 Financials
- 9.7.3 Product Portfolio
- 9.7.4 Business Strategy
- 9.7.5 Recent Developments
- 9.8 Agilent Technologies Inc.
- 9.8.1 Overview
- 9.8.2 Financials
- 9.8.3 Product Portfolio
- 9.8.4 Business Strategy
- 9.8.5 Recent Developments
- 9.9 Thermo Fisher Scientific Inc.
- 9.9.1 Overview
- 9.9.2 Financials
- 9.9.3 Product Portfolio
- 9.9.4 Business Strategy
- 9.9.5 Recent Developments
- 9.10 GE HealthCare Technologies Inc.
- 9.10.1 Overview
- 9.10.2 Financials
- 9.10.3 Product Portfolio
- 9.10.4 Business Strategy
- 9.10.5 Recent Developments
- 9.11 Illumina Inc.
- 9.11.1 Overview
- 9.11.2 Financials
- 9.11.3 Product Portfolio
- 9.11.4 Business Strategy
- 9.11.5 Recent Developments
- 9.12 Becton
- 9.12.1 Overview
- 9.12.2 Financials
- 9.12.3 Product Portfolio
- 9.12.4 Business Strategy
- 9.12.5 Recent Developments
- 9.13 Dickinson and Company
- 9.13.1 Overview
- 9.13.2 Financials
- 9.13.3 Product Portfolio
- 9.13.4 Business Strategy
- 9.13.5 Recent Developments
- 9.14 Guardant Health Inc.
- 9.14.1 Overview
- 9.14.2 Financials
- 9.14.3 Product Portfolio
- 9.14.4 Business Strategy
- 9.14.5 Recent Developments
- 9.15 Myriad Genetics Inc.
- 9.15.1 Overview
- 9.15.2 Financials
- 9.15.3 Product Portfolio
- 9.15.4 Business Strategy
- 9.15.5 Recent Developments
- 9.16 Bio-Rad Laboratories Inc.
- 9.16.1 Overview
- 9.16.2 Financials
- 9.16.3 Product Portfolio
- 9.16.4 Business Strategy
- 9.16.5 Recent Developments
- 9.17 and others.
- 9.17.1 Overview
- 9.17.2 Financials
- 9.17.3 Product Portfolio
- 9.17.4 Business Strategy
- 9.17.5 Recent Developments
- 9.1 Exact Sciences Corporation
Table Of Figures
- 1. Market research Type
- 2. Market research methodology
- 3. Global Lung Tumor Market, 2025 - 2034 (USD Billion)
- 4. Porter’s Five Forces Analysis
- 5. Global Lung Tumor Market attractiveness, By Product
- 6. Global Lung Tumor Market attractiveness, By Application
- 7. Global Lung Tumor Market attractiveness, By End-User Vertical
- 8. Global Lung Tumor Market share by Product, 2025 and 2034 (USD Billion)
- 9. Global Lung Tumor Market by Targeted Therapies, 2025 - 2034 (USD Billion)
- 10. Global Lung Tumor Market by Chemotherapy Drugs, 2025 - 2034 (USD Billion)
- 11. Global Lung Tumor Market by Imaging Systems, 2025 - 2034 (USD Billion)
- 12. Global Lung Tumor Market by Surgical Instruments, 2025 - 2034 (USD Billion)
- 13. Global Lung Tumor Market by Biopsy Needles & Devices, 2025 - 2034 (USD Billion)
- 14. Global Lung Tumor Market by Radiation Therapy Equipment, 2025 - 2034 (USD Billion)
- 15. Global Lung Tumor Market by Others, 2025 - 2034 (USD Billion)
- 16. Global Lung Tumor Market share by Application, 2025 and 2034 (USD Billion)
- 17. Global Lung Tumor Market by Treatment, 2025 - 2034 (USD Billion)
- 18. Global Lung Tumor Market by Early Detection, 2025 - 2034 (USD Billion)
- 19. Global Lung Tumor Market by Diagnosis, 2025 - 2034 (USD Billion)
- 20. Global Lung Tumor Market by Prognosis, 2025 - 2034 (USD Billion)
- 21. Global Lung Tumor Market share by End-User Vertical, 2025 and 2034 (USD Billion)
- 22. Global Lung Tumor Market by Imaging Centers, 2025 - 2034 (USD Billion)
- 23. Global Lung Tumor Market by Cancer Centers, 2025 - 2034 (USD Billion)
- 24. Global Lung Tumor Market by Hospitals & Clinics, 2025 - 2034 (USD Billion)
- 25. Global Lung Tumor Market by Research Institutions, 2025 - 2034 (USD Billion)
- 26. Global Lung Tumor Market share, by Region, 2025 and 2034
- 27. North America Lung Tumor Market, 2025 - 2034 (USD Billion)
- 28. Europe Lung Tumor Market, 2025 - 2034 (USD Billion)
- 29. Asia Pacific Lung Tumor Market, 2025 - 2034 (USD Billion)
- 30. Latin America Lung Tumor Market, 2025 - 2034 (USD Billion)
- 31. The Middle-East and Africa Lung Tumor Market, 2025 - 2034 (USD Billion)
Table Of Tables
- 1. Global Lung Tumor Market: Snapshot
- 2. Drivers of the Lung Tumor Market: impact analysis
- 3. North America Lung Tumor Market revenue, By Product, 2025 - 2034 (USD Billion)
- 4. North America Lung Tumor Market revenue, By Application, 2025 - 2034 (USD Billion)
- 5. North America Lung Tumor Market revenue, By End-User Vertical, 2025 - 2034 (USD Billion)
- 6. U.S. Lung Tumor Market revenue, By Product, 2025 - 2034 (USD Billion)
- 7. U.S. Lung Tumor Market revenue, By Application, 2025 - 2034 (USD Billion)
- 8. U.S. Lung Tumor Market revenue, By End-User Vertical, 2025 - 2034 (USD Billion)
- 9. Canada Lung Tumor Market revenue, By Product, 2025 - 2034 (USD Billion)
- 10. Canada Lung Tumor Market revenue, By Application, 2025 - 2034 (USD Billion)
- 11. Canada Lung Tumor Market revenue, By End-User Vertical, 2025 - 2034 (USD Billion)
- 12. Europe Lung Tumor Market revenue, By Product, 2025 - 2034 (USD Billion)
- 13. Europe Lung Tumor Market revenue, By Application, 2025 - 2034 (USD Billion)
- 14. Europe Lung Tumor Market revenue, By End-User Vertical, 2025 - 2034 (USD Billion)
- 15. Germany Lung Tumor Market revenue, By Product, 2025 - 2034 (USD Billion)
- 16. Germany Lung Tumor Market revenue, By Application, 2025 - 2034 (USD Billion)
- 17. Germany Lung Tumor Market revenue, By End-User Vertical, 2025 - 2034 (USD Billion)
- 18. France Lung Tumor Market revenue, By Product, 2025 - 2034 (USD Billion)
- 19. France Lung Tumor Market revenue, By Application, 2025 - 2034 (USD Billion)
- 20. France Lung Tumor Market revenue, By End-User Vertical, 2025 - 2034 (USD Billion)
- 21. U.K. Lung Tumor Market revenue, By Product, 2025 - 2034 (USD Billion)
- 22. U.K. Lung Tumor Market revenue, By Application, 2025 - 2034 (USD Billion)
- 23. U.K. Lung Tumor Market revenue, By End-User Vertical, 2025 - 2034 (USD Billion)
- 24. Italy Lung Tumor Market revenue, By Product, 2025 - 2034 (USD Billion)
- 25. Italy Lung Tumor Market revenue, By Application, 2025 - 2034 (USD Billion)
- 26. Italy Lung Tumor Market revenue, By End-User Vertical, 2025 - 2034 (USD Billion)
- 27. Spain Lung Tumor Market revenue, By Product, 2025 - 2034 (USD Billion)
- 28. Spain Lung Tumor Market revenue, By Application, 2025 - 2034 (USD Billion)
- 29. Spain Lung Tumor Market revenue, By End-User Vertical, 2025 - 2034 (USD Billion)
- 30. Rest of Europe Lung Tumor Market revenue, By Product, 2025 - 2034 (USD Billion)
- 31. Rest of Europe Lung Tumor Market revenue, By Application, 2025 - 2034 (USD Billion)
- 32. Rest of Europe Lung Tumor Market revenue, By End-User Vertical, 2025 - 2034 (USD Billion)
- 33. Asia Pacific Lung Tumor Market revenue, By Product, 2025 - 2034 (USD Billion)
- 34. Asia Pacific Lung Tumor Market revenue, By Application, 2025 - 2034 (USD Billion)
- 35. Asia Pacific Lung Tumor Market revenue, By End-User Vertical, 2025 - 2034 (USD Billion)
- 36. China Lung Tumor Market revenue, By Product, 2025 - 2034 (USD Billion)
- 37. China Lung Tumor Market revenue, By Application, 2025 - 2034 (USD Billion)
- 38. China Lung Tumor Market revenue, By End-User Vertical, 2025 - 2034 (USD Billion)
- 39. Japan Lung Tumor Market revenue, By Product, 2025 - 2034 (USD Billion)
- 40. Japan Lung Tumor Market revenue, By Application, 2025 - 2034 (USD Billion)
- 41. Japan Lung Tumor Market revenue, By End-User Vertical, 2025 - 2034 (USD Billion)
- 42. India Lung Tumor Market revenue, By Product, 2025 - 2034 (USD Billion)
- 43. India Lung Tumor Market revenue, By Application, 2025 - 2034 (USD Billion)
- 44. India Lung Tumor Market revenue, By End-User Vertical, 2025 - 2034 (USD Billion)
- 45. South Korea Lung Tumor Market revenue, By Product, 2025 - 2034 (USD Billion)
- 46. South Korea Lung Tumor Market revenue, By Application, 2025 - 2034 (USD Billion)
- 47. South Korea Lung Tumor Market revenue, By End-User Vertical, 2025 - 2034 (USD Billion)
- 48. South-East Asia Lung Tumor Market revenue, By Product, 2025 - 2034 (USD Billion)
- 49. South-East Asia Lung Tumor Market revenue, By Application, 2025 - 2034 (USD Billion)
- 50. South-East Asia Lung Tumor Market revenue, By End-User Vertical, 2025 - 2034 (USD Billion)
- 51. Rest of Asia Pacific Lung Tumor Market revenue, By Product, 2025 - 2034 (USD Billion)
- 52. Rest of Asia Pacific Lung Tumor Market revenue, By Application, 2025 - 2034 (USD Billion)
- 53. Rest of Asia Pacific Lung Tumor Market revenue, By End-User Vertical, 2025 - 2034 (USD Billion)
- 54. Latin America Lung Tumor Market revenue, By Product, 2025 - 2034 (USD Billion)
- 55. Latin America Lung Tumor Market revenue, By Application, 2025 - 2034 (USD Billion)
- 56. Latin America Lung Tumor Market revenue, By End-User Vertical, 2025 - 2034 (USD Billion)
- 57. Brazil Lung Tumor Market revenue, By Product, 2025 - 2034 (USD Billion)
- 58. Brazil Lung Tumor Market revenue, By Application, 2025 - 2034 (USD Billion)
- 59. Brazil Lung Tumor Market revenue, By End-User Vertical, 2025 - 2034 (USD Billion)
- 60. Mexico Lung Tumor Market revenue, By Product, 2025 - 2034 (USD Billion)
- 61. Mexico Lung Tumor Market revenue, By Application, 2025 - 2034 (USD Billion)
- 62. Mexico Lung Tumor Market revenue, By End-User Vertical, 2025 - 2034 (USD Billion)
- 63. Rest of Latin America Lung Tumor Market revenue, By Product, 2025 - 2034 (USD Billion)
- 64. Rest of Latin America Lung Tumor Market revenue, By Application, 2025 - 2034 (USD Billion)
- 65. Rest of Latin America Lung Tumor Market revenue, By End-User Vertical, 2025 - 2034 (USD Billion)
- 66. The Middle-East and Africa Lung Tumor Market revenue, By Product, 2025 - 2034 (USD Billion)
- 67. The Middle-East and Africa Lung Tumor Market revenue, By Application, 2025 - 2034 (USD Billion)
- 68. The Middle-East and Africa Lung Tumor Market revenue, By End-User Vertical, 2025 - 2034 (USD Billion)
- 69. GCC Countries Lung Tumor Market revenue, By Product, 2025 - 2034 (USD Billion)
- 70. GCC Countries Lung Tumor Market revenue, By Application, 2025 - 2034 (USD Billion)
- 71. GCC Countries Lung Tumor Market revenue, By End-User Vertical, 2025 - 2034 (USD Billion)
- 72. South Africa Lung Tumor Market revenue, By Product, 2025 - 2034 (USD Billion)
- 73. South Africa Lung Tumor Market revenue, By Application, 2025 - 2034 (USD Billion)
- 74. South Africa Lung Tumor Market revenue, By End-User Vertical, 2025 - 2034 (USD Billion)
- 75. Rest of Middle-East Africa Lung Tumor Market revenue, By Product, 2025 - 2034 (USD Billion)
- 76. Rest of Middle-East Africa Lung Tumor Market revenue, By Application, 2025 - 2034 (USD Billion)
- 77. Rest of Middle-East Africa Lung Tumor Market revenue, By End-User Vertical, 2025 - 2034 (USD Billion)
Methodology
FrequentlyAsked Questions
Lung tumor refers to an abnormal growth or mass of cells in the lung airways or tissues. Lung tumor can spread from tumors in other parts of the body, or they can begin in the lungs themselves.
The global lung tumor market is expected to be influenced by the growing prevalence of lung cancer worldwide.
According to study, the global lung tumor market size was worth around USD 5.82 billion in 2024 and is predicted to grow to around USD 10.51 billion by 2034.
The CAGR value of lung tumor market is expected to be around 6.67% during 2025-2034.
The global lung tumor industry is expected to be challenged by the biological complexity of the tumors.
The lung tumor market is highly competitive with several biotechnology and pharmaceutical companies aiming to enhance access to targeted therapies and early detection.
The lung tumor market is expected to shift toward non-invasive diagnostic and treatment procedures during the forecast period.
Asia-Pacific is projected to emerge as the fastest-growing region with a CAGR of 25% during the forecast period.
The global lung tumor market is led by players like Exact Sciences Corporation, F. Hoffmann-La Roche Ltd, QIAGEN N.V., Abbott Laboratories, Siemens Healthineers AG, Koninklijke Philips N.V., Danaher Corporation, Agilent Technologies, Inc., Thermo Fisher Scientific Inc., GE HealthCare Technologies Inc., Illumina, Inc., Becton, Dickinson and Company, Guardant Health, Inc., Myriad Genetics, Inc. and Bio-Rad Laboratories, Inc.
The report explores crucial aspects of the lung tumor market including detailed discussion of existing growth factors and restraints while also browsing future growth opportunities and challenges that impact the market.
HappyClients
